
    
      The purpose of this observational study is to examine 1) the risk of adverse events (AEs)
      following vaccination with 10 or 13-valent pneumococcal conjugate vaccine (PCV10 or PCV13)
      among infants or children age <59 months using a self-controlled risk interval design and 2)
      the risk of AEs following vaccination with 23-valent pneumococcal polysaccharide vaccine
      (PPSV23) among adults age 65 years and older compared with influenza vaccine recipients using
      a cohort design. We will use the national health insurance database from the National Health
      Insurance Service (NHIS) linked with the national immunization program registry data from the
      Korea Centers for Diseases Control & Prevention (KCDC).
    
  